Nasonex

Medicinal product

(Invented) name

Nasonex

Active substance (s)

Mometazono furoatas

Strength

50 µg/dozėje

Pharmaceutical form

nosies purškalas (suspensija)

Route (s) of administration

vartoti į nosį

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

R01AD09, Mometasone

Marketing authorisation holder

N.V. Organon, Nyderlandai

Date of authorisation

1997-12-22

Date of renewal

2009-10-14

Documents

1731 Pakuotės lapelis 2022 11 14.docx

1731 Nasonex II PL 2022 11 14.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

SE/H/1821/001

Marketing authorisation procedure

Savitarpio pripažinimo procedūra

Qualitative and quantitative composition

Dozėje yra	1 dozėje
Mometazono furoatas	50 µg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
6193	3843	1003843	buteliukas	140 dozių N1		Receptinis	LT/1/97/1731/001	Tiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2009-10-14	Perregistruotas
1997-12-22	Registruotas